Portfolio Update

BLACKROCK SMALLER COMPANIES TRUST PLC All information is at 31 OCTOBER 2011 and unaudited. Performance at month end is calculated on a capital only basis One Three One Three Five Month Months Year Years Years Net asset value 5.1% -13.0% 3.0% 119.3% 39.0% Share price 2.8% -15.5% 5.6% 142.0% 33.9% HGSC ex Inv Trust + AIM* 4.4% -11.6% -3.6% 70.6% -13.1% Sources: BlackRock and Datastream *With effect from 1 September 2007 the Hoare Govett Smaller Companies plus AIM (ex Investment Companies) Index replaced the FTSE SmallCap Index (ex Investment Companies) as the Company's benchmark. For the five year period the above index has been blended to reflect this. At month end Net asset value Capital only (debt at par value): 541.32p Net asset value Capital only (debt at fair value): 537.11p Net asset value incl. Income (debt at par value): 546.88p** Net asset value incl. Income (debt at fair value): 542.66p** Share price: 452.50p Discount to Cum Income NAV (debt at par value): 17.3% Discount to Cum Income NAV (debt at fair value): 16.6% Net yield: 1.6% Total assets: £276.7m^ Gearing incl. Income (debt at par value): 5.4% Gearing incl. Income (debt at fair value): 6.1% Ordinary shares in issue: 47,879,792^^ **includes net revenue of 5.56p ^includes current year revenue ^^excludes 2,113,731 shares held in treasury Ten Largest Sector Weightings % of total assets Software & Computer Services 9.7 Support Services 8.8 Electronic & Electrical Equipment 7.8 Financial Services 6.8 Industrial Metals & Mining 6.8 Oil & Gas Producers 6.4 Household Goods & Home Construction 5.7 Media 5.7 General Retailers 5.5 Pharmaceuticals & Biotechnology 4.9 ---- Total 68.1 ==== Ten Largest Equity Investments (in alphabetical order) Company Aveva Group Bellway Blinkx Fidessa group Hargreaves Services Immunodiagnostic Systems ITE Group City of London Investment Group Oxford Instruments Senior Commenting on the markets, Mike Prentis, representing the Investment Manager noted: October was a rather better month for markets and our portfolio. The NAV on a capital only basis rose by 5.1%, whereas the benchmark rose by 4.4%. The FTSE 100 Index increased by 8.1% during the month. Outperformance during the month was mainly derived from sector allocation and gearing. Although the contribution from sector allocation was good, this was from a variety of sector positions with no one position being significant. Gearing had been reduced over the previous months but still made a useful contribution in rising markets. Newsflow from the portfolio was generally good, although we did get disappointing statements from Vectura, where further trials will be required for a key drug, and IQE, which saw slower growth due to destocking. We continue to hold these stocks. On the positive side, Sierra Rutile attracted an offer from its largest shareholder at a good premium. We continued to sell a number of holdings where our conviction was not high enough, or where gearing or valuations were too high for current markets. The proceeds were generally used to reduce our borrowing. Many uncertainties persist at the macro level, most importantly achieving a satisfactory resolution to the funding and debt problems in Greece, Italy and other economies. These uncertainties are inevitably having an impact on the decision making and activity levels of individual companies. We have already seen various downgrades to forecasts, for instance from IQE as mentioned above, and we suspect that more are in the pipeline. 14 November 2011 ENDS Latest information is available by typing www.blackrock.co.uk/brsc on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings